Cargando…
Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme
OBJECTIVES: The SABINA CHINA study aimed to determine prescription data for asthma medication with a focus on SABA and ICS in a representative population of patients with asthma in China. METHODS: SABINA China was a multicentre, observational, cross-sectional study with data collected retrospectivel...
Autores principales: | Bao, Wuping, Zhang, Yingying, Hang, Jingqing, Guo, Yubiao, Tang, Wei, Yun, Chunmei, Deng, Jingmin, Jin, Meiling, Lai, Kefang, Yu, Huapeng, Beekman, Maarten, Zhou, Xin, Zhang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449520/ https://www.ncbi.nlm.nih.gov/pubmed/36065527 http://dx.doi.org/10.1177/17534666221115054 |
Ejemplares similares
-
Short-acting β(2)-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III
por: Yorgancıoğlu, Arzu, et al.
Publicado: (2022) -
Short-acting β(2)-agonist prescription patterns for asthma management in the SABINA III primary care cohort
por: Price, David, et al.
Publicado: (2022) -
Over-prescription of short-acting β(2)-agonists remains a serious health concern in Kenya: results from the SABINA III study
por: Chakaya, Jeremiah, et al.
Publicado: (2023) -
Over-prescription of short-acting β(2)-agonists for asthma in South Africa: Results from the SABINA III study
por: Smith, C, et al.
Publicado: (2022) -
Short-acting β(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
por: Bateman, Eric D., et al.
Publicado: (2022)